|
VPS37C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.335100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.217600E-02 |
| Normal-vs-Stage2 |
1.182410E-01 |
| Normal-vs-Stage3 |
1.997060E-03 |
| Normal-vs-Stage4 |
2.455900E-02 |
| Stage1-vs-Stage2 |
7.101400E-01 |
| Stage1-vs-Stage3 |
6.714500E-02 |
| Stage1-vs-Stage4 |
3.006400E-01 |
| Stage2-vs-Stage3 |
3.903000E-01 |
| Stage2-vs-Stage4 |
6.275000E-01 |
| Stage3-vs-Stage4 |
8.143600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.463300E-03 |
| Normal-vs-AfricanAmerican |
9.679600E-01 |
| Normal-vs-Asian |
4.335000E-01 |
| Caucasian-vs-AfricanAmerican |
2.257800E-02 |
| Caucasian-vs-Asian |
7.806000E-01 |
| AfricanAmerican-vs-Asian |
5.216200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.123300E-03 |
| Normal-vs-Female |
2.737200E-01 |
| Male-vs-Female |
6.603700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.662300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.161170E-01 |
| Normal-vs-Age(61-80Yrs) |
9.552600E-04 |
| Normal-vs-Age(81-100Yrs) |
7.829200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.030000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.455000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.605000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.038120E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.762400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.100100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.299330E-03 |
| Normal-vs-Grade 2 |
3.602200E-02 |
| Normal-vs-Grade 3 |
6.102900E-03 |
| Normal-vs-Grade 4 |
1.559200E-03 |
| Grade 1-vs-Grade 2 |
5.57769999999236E-05 |
| Grade 1-vs-Grade 3 |
1.601360E-04 |
| Grade 1-vs-Grade 4 |
1.67366999999086E-05 |
| Grade 2-vs-Grade 3 |
3.963600E-01 |
| Grade 2-vs-Grade 4 |
7.666500E-02 |
| Grade 3-vs-Grade 4 |
3.266000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.405600E-01 |
| Normal-vs-ccB subtype |
1.232630E-04 |
| ccA subtype-vs-ccB subtype |
8.46469999999933E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.415400E-03 |
| Normal-vs-N1 |
2.010600E-01 |
| N0-vs-N1 |
8.841600E-01 |
|
|
